UBS Group’s HealthCor Catalio Acquisition Corp. Class A Ordinary Shares HCAQ Stock Holding History

UBS Group’s Portfolio HCAQ Stock Details HCAQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,721	Closed	-$37K	–	11260
2021 Q3	$37K	Buy	+3,721	New	+$36.8K	﹤0.01%	6586

UBS Group's HCAQ Position: Q4 2021 in Review

UBS Group sold out of HealthCor Catalio Acquisition Corp. Class A Ordinary Shares (HCAQ) in Q4 2021, closing a stake of 3,721 shares — an estimated $37K sold.

UBS Group first reported a position in HCAQ in Q3 2021 and held it in 1 quarter. The position peaked at $37K in Q3 2021. 0 funds tracked by Wall St. Rank hold HCAQ as of Q4 2021.

UBS Group reported no remaining HealthCor Catalio Acquisition Corp. Class A Ordinary Shares position as of Q4 2021 after selling out during the quarter.
UBS Group sold 3,721 HealthCor Catalio Acquisition Corp. Class A Ordinary Shares shares in Q4 2021, an estimated $37K.
UBS Group first reported a position in HealthCor Catalio Acquisition Corp. Class A Ordinary Shares in Q3 2021 and held it in 1 quarter.
UBS Group's HealthCor Catalio Acquisition Corp. Class A Ordinary Shares position peaked at $37K in Q3 2021.
0 funds tracked by Wall St. Rank held HealthCor Catalio Acquisition Corp. Class A Ordinary Shares as of Q4 2021.

Based on UBS Group's 13F filing for Q4 2021, filed 14 Feb 2022.